# Consolidated Research Findings & Prioritized Roadmap
## Biodata Inventory ML Pipeline Modernization

**Date**: 2025-10-29
**Status**: Ready for Implementation
**Current Baseline**: Classification F1=0.898, NER F1=0.749
**Critical Challenge**: Small NER dataset (554 samples), severe overfitting (train/val gap=0.353)

---

## Executive Summary

This consolidated report synthesizes findings from **4 comprehensive research reports** covering modern ML alternatives, data augmentation, few-shot learning, and ensemble/multi-task methods. After analyzing 100+ recent papers (2023-2025) and evaluating 30+ techniques, we've identified a clear, prioritized path to improve model performance by **+10-18% F1** for NER and **+2-5% F1** for classification.

### Key Consensus Recommendations

All four reports converge on these critical priorities:

1. **Hyperparameter Optimization** (ALL 4 REPORTS) - Immediate 3-5% F1 gain, fixes training instability
2. **Modern Biomedical Base Model** (3/4 REPORTS) - BioLinkBERT or PubMedBERT for +2-4% F1
3. **Data Augmentation for NER** (3/4 REPORTS) - UMLS-EDA + LLM generation for +5-10% F1
4. **TAPT (Task-Adaptive Pre-Training)** (2/4 REPORTS) - Leverage 21,677 unlabeled papers for +8-15% F1
5. **Parameter-Efficient Fine-Tuning** (2/4 REPORTS) - LoRA reduces overfitting, saves memory

### What NOT to Do (Consensus)

- **Traditional Ensembles** (3-10 models): High cost (3-10x), modest gains (+1-3%)
- **Multi-Task Learning**: HIGH complexity, negative transfer risk, conditional recommendation only
- **Advanced optimizers** (Lion, Sophia): No clear advantage over AdamW with proper hyperparameters
- **Model quantization**: -1-2% F1 penalty, only for deployment optimization

---

## Table of Contents

1. [Prioritized Roadmap (3 Phases)](#prioritized-roadmap)
2. [Comprehensive Recommendations by Category](#comprehensive-recommendations)
3. [Implementation Priorities Matrix](#implementation-priorities)
4. [Expected Outcomes Timeline](#expected-outcomes)
5. [Cost Analysis](#cost-analysis)
6. [Risk Assessment](#risk-assessment)
7. [Decision Framework](#decision-framework)
8. [Detailed Report Links](#references)

---

<a name="prioritized-roadmap"></a>
## Prioritized Roadmap

### Phase 1: Immediate Quick Wins (Week 1)
**Goal**: Fix training instability, establish solid baseline
**Expected NER F1**: 0.749 → 0.800-0.820 (+7-9%)
**Expected Classification F1**: 0.898 → 0.910-0.920 (+1-2%)

#### Week 1, Days 1-2: Critical Hyperparameter Fixes

| Action | Current → New | Rationale | Expected Gain |
|--------|--------------|-----------|---------------|
| **Learning Rate** | 2e-5 → 5e-6 | Too high, causing training instability | +2-3% F1 |
| **Weight Decay** | 0.0 → 0.01 | Essential regularization missing | +2-3% F1 |
| **Early Stopping** | None → patience=3 | Model peaked at epoch 4, trained to 10 | +3-5% F1 |
| **Warmup Ratio** | 0.0 → 0.1 | Stabilizes initial training | +0.5-1% F1 |
| **LR Scheduler** | Linear → Cosine | Better final convergence | +0.5-1% F1 |

**Implementation**:
```python
training_args = TrainingArguments(
    learning_rate=5e-6,              # ← CRITICAL: Reduced from 2e-5
    weight_decay=0.01,               # ← CRITICAL: Was 0.0
    warmup_ratio=0.1,                # ← NEW
    lr_scheduler_type="cosine",      # ← Changed from linear
    evaluation_strategy="epoch",
    save_strategy="epoch",
    load_best_model_at_end=True,     # ← CRITICAL
    metric_for_best_model="eval_f1", # ← CRITICAL
)

# Add early stopping callback
from transformers import EarlyStoppingCallback
trainer = Trainer(
    callbacks=[EarlyStoppingCallback(early_stopping_patience=3)]
)
```

**Validation**: Train both models (classification + NER), compare to V2 baseline

---

#### Week 1, Days 3-4: Modern Base Model Switch

**Action**: Replace current base model with BioLinkBERT or PubMedBERT

**Recommendation Matrix**:

| Model | Size | Best For | F1 Gain | Memory | Priority |
|-------|------|----------|---------|--------|----------|
| **BioLinkBERT-base** | 110M | Balance of performance/resources | +2-3% | 15GB (T4 OK) | **HIGHEST** |
| PubMedBERT-base | 110M | Conservative, proven choice | +2-4% | 15GB (T4 OK) | HIGH |
| BioLinkBERT-large | 340M | Maximum performance | +3-4% | 20GB (A100) | MEDIUM |

**Evidence**:
- BioLinkBERT: +7% on BioASQ, +3% BLURB benchmark average
- Citation-aware pretraining helps with database/resource detection
- All 3 reports recommend modern biomedical models

**Implementation**:
```python
# Simple drop-in replacement
model_name = "michiyasunaga/BioLinkBERT-base"  # Recommended
# OR
model_name = "microsoft/BiomedNLP-PubMedBERT-base-uncased-abstract-fulltext"

tokenizer = AutoTokenizer.from_pretrained(model_name)
model = AutoModelForTokenClassification.from_pretrained(model_name, num_labels=5)
```

**Timeline**: 2 days (1 day testing + 1 day full training)

---

#### Week 1, Day 5: Add LoRA Fine-Tuning

**Action**: Implement LoRA to reduce overfitting on small NER dataset

**Benefits**:
- 99.5% fewer trainable parameters (110M → ~600K)
- 30-40% memory reduction
- Better generalization on small datasets
- Same or better F1 than full fine-tuning

**Implementation**:
```python
from peft import LoraConfig, get_peft_model, TaskType

lora_config = LoraConfig(
    task_type=TaskType.TOKEN_CLS,
    r=16,                           # Rank (start with 16)
    lora_alpha=16,                  # Scaling factor
    lora_dropout=0.1,               # NER: 0.1-0.2 for small datasets
    target_modules=["query", "value", "key"],  # Q, K, V for NER
    bias="all"                      # Adapt bias for token classification
)

model = get_peft_model(model, lora_config)
model.print_trainable_parameters()
# trainable params: ~600K || all params: 110M || trainable%: 0.54%
```

**Expected**: +0-3% F1 (matches or exceeds full fine-tuning with reduced overfitting)

---

### Phase 1 Summary

**Total Time**: 1 week (5 days)
**Cost**: $0 (all free/open-source)
**Risk**: Very Low (proven techniques)
**Expected Outcome**:
- NER F1: 0.749 → 0.800-0.820 (+7-9%)
- Classification F1: 0.898 → 0.910-0.920 (+1-2%)
- Stable training (no more bouncing/instability)
- Reduced overfitting (train/val gap < 0.15)

**Success Criteria**: NER F1 ≥ 0.800 on validation set

---

### Phase 2: Strategic Data Expansion (Weeks 2-3)
**Goal**: Expand NER dataset from 554 to 1,500+ samples
**Expected NER F1**: 0.800 → 0.850-0.870 (+5-7% additional)
**Expected Classification F1**: Stable at 0.910-0.920

#### Week 2, Days 1-2: UMLS-EDA Implementation (PRIMARY)

**What**: Entity-aware augmentation using UMLS medical terminology

**Why #1**:
- Proven: +5-17% F1 on biomedical NER (published research)
- Entity-safe: Preserves BIO tags automatically
- Free: No API costs
- Fast: Local processing

**Implementation Steps**:

1. **Setup UMLS** (one-time, ~2 hours):
   ```bash
   # Register for free UMLS license
   # Download UMLS Metathesaurus (~10GB)
   pip install quickumls
   python -m quickumls.install <umls_path>
   ```

2. **Install UMLS-EDA** (30 min):
   ```bash
   git clone https://github.com/WengLab-InformaticsResearch/UMLS-EDA
   cd UMLS-EDA
   pip install -r requirements.txt
   ```

3. **Generate Augmented Data** (2-4 hours):
   ```python
   from umls_eda import augment_ner_dataset

   augmented_data = augment_ner_dataset(
       original_data=train_ner_data,  # 554 samples
       alpha=0.2,                      # 20% of words modified
       num_aug=2,                      # 2 augmented versions per sample
       operations=['sr', 'ri', 'rs']   # Synonym, Insert, Swap
   )
   # Output: 554 → 1,662 samples (3x)
   ```

4. **Quality Validation** (1 day):
   - Automated: BIO tag consistency check
   - Manual: Review 50-100 samples (10%)
   - Filter: Remove low-quality generations

**Expected Outcome**:
- 1,100-1,600 samples total (554 original + augmented)
- +5-10% F1 improvement
- Augmentation ratio: 2-3x

**Timeline**: 3 days total

---

#### Week 2, Days 3-5: LLM-Assisted Generation (COMPLEMENTARY)

**What**: Use GPT-4 to generate synthetic biomedical text with entity annotations

**Why #2**:
- High quality: Realistic scientific text
- Diversity: Different contexts, sentence structures
- Proven: +17.8% accuracy in 2024 MedSyn study
- Controllable: Prompt engineering for precision

**Implementation**:

1. **Prompt Template** (Few-Shot):
   ```
   You are a biomedical annotation expert. Generate realistic scientific abstract
   sentences mentioning biomedical databases/resources with BIO annotations.

   Examples:
   Text: "We deposited data in Gene Expression Omnibus (GEO)."
   Tags: O O O O B-FUL I-FUL I-FUL B-COM

   Text: "The TCGA project contains comprehensive cancer data."
   Tags: O B-COM O O O O O

   Generate 5 new sentences with BIO tags (O, B-COM, I-COM, B-FUL, I-FUL).
   ```

2. **Batch Generation** (0.5-1 day):
   ```python
   import openai

   # Generate 200-300 samples
   for i in range(0, 300, 5):  # 5 samples per API call
       response = openai.ChatCompletion.create(
           model="gpt-4",
           messages=[{"role": "user", "content": prompt}],
           temperature=0.7
       )
       samples = parse_bio_annotations(response)
       validate_bio_consistency(samples)
   ```

3. **Quality Control** (1 day):
   - Automated: BIO tag validation, duplicate detection
   - Manual: Review 20% (40-60 samples)
   - Filter: Remove hallucinated database names

**Expected Outcome**:
- 200-300 high-quality diverse samples
- +3-5% F1 improvement (on top of UMLS-EDA)
- Cost: $30-50 for GPT-4 API

**Timeline**: 2-3 days total

---

#### Week 3: TAPT (Task-Adaptive Pre-Training)

**What**: Continue pre-training base model on 21,677 unlabeled papers

**Why**:
- Proven: +8-15% F1 in similar scenarios (clinical notes study)
- Leverage unlabeled data: Domain adaptation for database/resource terminology
- Synergy: Combines with data augmentation for maximum effect

**Implementation**:

1. **Prepare Corpus** (2-3 hours):
   ```python
   import pandas as pd

   df = pd.read_csv("data/2022_europepmc_results.csv")
   texts = (df['title'] + ' ' + df['abstractText']).tolist()

   with open('data/tapt_corpus.txt', 'w') as f:
       for text in texts:
           f.write(text.strip() + '\n')
   ```

2. **Run TAPT Training** (6-8 hours on Colab T4):
   ```python
   from transformers import AutoModelForMaskedLM, DataCollatorForLanguageModeling

   model = AutoModelForMaskedLM.from_pretrained("michiyasunaga/BioLinkBERT-base")

   trainer = Trainer(
       model=model,
       args=TrainingArguments(
           output_dir="models/tapt_adapted",
           num_train_epochs=3,
           per_device_train_batch_size=16,
           learning_rate=1e-4,
           weight_decay=0.01,
           warmup_ratio=0.06
       ),
       train_dataset=tokenized_corpus,
       data_collator=DataCollatorForLanguageModeling(tokenizer, mlm_probability=0.15)
   )
   trainer.train()
   ```

3. **Fine-Tune NER on TAPT Model** (~9.5 hours):
   ```python
   # Use TAPT-adapted model as base
   model = AutoModelForTokenClassification.from_pretrained(
       "models/tapt_adapted",
       num_labels=5
   )
   # Train with augmented data + optimized hyperparameters
   ```

**Expected Outcome**:
- +8-15% F1 improvement over baseline
- Better domain-specific representations
- Total: 554 original + 946 augmented + TAPT = Best results

**Timeline**: 4-5 days (1 day prep + 1 day TAPT + 1 day NER training + 1-2 days validation)

---

### Phase 2 Summary

**Total Time**: 2-3 weeks (10-15 days)
**Cost**: $30-50 (GPT-4 API for LLM generation)
**Risk**: Low-Medium (proven techniques, requires validation)
**Expected Outcome**:
- NER dataset: 554 → 1,500+ samples
- NER F1: 0.800 → 0.850-0.870 (+5-7% additional)
- Classification F1: 0.910-0.920 (stable)
- Combined Phase 1+2: NER +12-16% total improvement

**Success Criteria**: NER F1 ≥ 0.850 on validation set

---

### Phase 3: Advanced Techniques (Weeks 4-6, Optional)
**Goal**: Squeeze out remaining performance gains
**Expected NER F1**: 0.850 → 0.870-0.880 (+2-3% additional)
**Expected Classification F1**: 0.920 → 0.925-0.930 (+0.5-1%)

#### Option A: Self-Training with Pseudo-Labels

**What**: Iteratively expand training set using high-confidence predictions

**Process**:
1. Train model on augmented data (1,500 samples)
2. Predict on remaining 20,177 unlabeled papers
3. Select high-confidence predictions (confidence > 0.95)
4. Add 500-1,000 pseudo-labeled samples to training set
5. Retrain model
6. Repeat 2-3 times

**Expected**: +5-12% F1 (1,500 → 2,500-3,000 effective samples)
**Timeline**: 1 week (3 iterations × 2-3 days)
**Risk**: Medium (error propagation if confidence threshold too low)

---

#### Option B: Contrastive Learning (Token-Level)

**What**: Learn better token representations by clustering same-entity tokens

**Benefits**:
- +5-10% F1 improvement in few-shot scenarios
- Better handling of rare entity types
- Synergizes with TAPT and data augmentation

**Implementation**:
```python
class ContrastiveNERLoss(nn.Module):
    def forward(self, embeddings, labels):
        # Pull same-entity tokens together
        # Push different-entity tokens apart
        # Token-level supervised contrastive learning
```

**Expected**: +2-5% F1
**Timeline**: 1 week (implementation + tuning)
**Risk**: Medium (requires hyperparameter tuning)

---

#### Option C: Multi-Task Learning (CONDITIONAL)

**What**: Train classification + NER jointly with shared encoder

**ONLY PURSUE IF**:
- ✅ Phase 1-2 completed successfully
- ✅ NER F1 < 0.850 after Phase 2
- ✅ Can afford 1-2 weeks implementation time
- ✅ Accept risk of negative transfer

**Expected**: +1-3% NER F1, +0.5-1% Classification F1
**Timeline**: 2 weeks (1 week implementation + 1 week tuning)
**Risk**: HIGH (negative transfer possible, complex debugging)

**Decision Criteria**:
- ✅ Proceed if both tasks improve or stay same
- ⚠️ Adjust if one task degrades slightly (< 2%)
- ❌ Abandon if significant degradation (> 2%)

---

### Phase 3 Summary

**Total Time**: 1-3 weeks (depending on options pursued)
**Cost**: $0-50 (if using LLMs for self-training validation)
**Risk**: Medium-High (experimental techniques)
**Expected Outcome**:
- NER F1: 0.850 → 0.870-0.880 (+2-3% additional)
- Classification F1: 0.920 → 0.925-0.930 (+0.5-1%)
- Combined Phases 1-3: NER +14-18% total improvement

**Success Criteria**: NER F1 ≥ 0.870, Classification F1 ≥ 0.920

---

<a name="comprehensive-recommendations"></a>
## Comprehensive Recommendations by Category

### 1. Hyperparameters (CONSENSUS: ALL 4 REPORTS)

| Parameter | Current | Recommended | Rationale | Impact |
|-----------|---------|-------------|-----------|--------|
| **Learning Rate** | 2e-5 | **5e-6 to 3e-5** | Current too high, causing instability | **HIGH** |
| **Weight Decay** | 0.0 | **0.01 (0.1 for NER)** | Essential regularization for small datasets | **HIGH** |
| **Early Stopping** | None | **patience=3-5** | Model peaked early, continued training degraded | **CRITICAL** |
| **LR Scheduler** | Linear | **Cosine** | Better final convergence | **MEDIUM** |
| **Warmup Ratio** | 0.0 | **0.1 (10%)** | Stabilizes initial training | **MEDIUM** |
| **Dropout** | 0.1 | **0.15-0.2 (NER)** | Higher for smaller datasets | **MEDIUM** |
| **Gradient Clipping** | 1.0 | **1.0 (keep)** | Already optimal | **LOW** |

**Evidence**:
- Oct 28 training showed bouncing with LR=2e-5
- Model peaked at epoch 4 (F1=0.739), declined to epoch 10 (F1=0.653)
- Weight decay=0.0 provides no regularization

---

### 2. Base Models (CONSENSUS: 3/4 REPORTS)

**Ranking**:

| Rank | Model | Size | Use Case | F1 Gain | Reports Supporting |
|------|-------|------|----------|---------|-------------------|
| **#1** | **BioLinkBERT-base** | 110M | Best overall balance | **+2-3%** | Modern ML, Few-Shot |
| #2 | PubMedBERT-base | 110M | Conservative choice | +2-4% | Modern ML, Ensemble |
| #3 | BioLinkBERT-large | 340M | Maximum performance | +3-4% | Modern ML |
| #4 | Current (AllenAI RoBERTa) | 125M | Baseline | 0% | - |

**Consensus**: BioLinkBERT-base offers best trade-off of performance, resources, and citation-aware pretraining

**Conflicting Recommendations**: None - all reports agree on modern biomedical models

---

### 3. Training Techniques (CONSENSUS: 2-3/4 REPORTS)

#### LoRA (Parameter-Efficient Fine-Tuning)
- **Reports**: Modern ML, Few-Shot
- **Benefit**: 99.5% fewer parameters, reduces overfitting
- **F1 Gain**: 0-3% (matches or exceeds full fine-tuning)
- **Priority**: **HIGH**

#### Mixed Precision Training (bfloat16)
- **Reports**: Modern ML
- **Benefit**: 1.5-2x faster training, no quality loss
- **F1 Gain**: 0% (speed optimization only)
- **Priority**: **HIGH** (implementation trivial)

#### Layer-Wise Learning Rate Decay (LLRD)
- **Reports**: Few-Shot, Modern ML
- **Benefit**: Better adaptation of upper layers while preserving pretrained knowledge
- **F1 Gain**: +1-2%
- **Priority**: **MEDIUM**

#### Label Smoothing
- **Reports**: Few-Shot, Modern ML
- **Benefit**: Better calibration, reduced overconfidence
- **F1 Gain**: +1-2%
- **Priority**: **MEDIUM**

---

### 4. Data Augmentation (CONSENSUS: 3/4 REPORTS)

**Ranking by Priority**:

| Technique | Quality | Complexity | F1 Gain | Cost | Reports | Priority |
|-----------|---------|------------|---------|------|---------|----------|
| **UMLS-EDA** | High | Low | **+5-17%** | Free | Data Aug, Few-Shot | **CRITICAL** |
| **LLM Generation (GPT-4)** | High | Medium | +3-8% | $30-50 | Data Aug, Few-Shot | **HIGH** |
| **TAPT** | High | Medium | +8-15% | Free | Few-Shot, Modern ML | **HIGH** |
| Contextual Entity Replacement | Med-High | Medium | +2-5% | Free | Data Aug | MEDIUM |
| Back-Translation | Medium | Medium | +2-4% | Free | Data Aug | MEDIUM |

**Consensus Strategy**:
1. UMLS-EDA for bulk augmentation (554 → 1,600)
2. GPT-4 for diversity (+ 200-300 samples)
3. TAPT for domain adaptation
4. Final dataset: 1,500-1,800 samples

**Expected Combined Effect**: +12-18% F1

---

### 5. Few-Shot Learning (CONSENSUS: 2/4 REPORTS)

#### Self-Training with Pseudo-Labels
- **Reports**: Few-Shot, Modern ML
- **Benefit**: Expands dataset using 21,677 unlabeled papers
- **F1 Gain**: +5-12%
- **Priority**: **HIGH** (Phase 3)
- **Risk**: Error propagation if confidence threshold too low

#### Contrastive Learning (Token-Level)
- **Reports**: Few-Shot, Modern ML
- **Benefit**: Better token representations, helps rare entities
- **F1 Gain**: +5-10%
- **Priority**: **MEDIUM** (Phase 3)
- **Complexity**: Medium-High

#### Prototypical Networks
- **Reports**: Few-Shot
- **Benefit**: Explicit few-shot learning framework
- **F1 Gain**: +4-8%
- **Priority**: **LOW** (experimental)

---

### 6. Ensemble/Multi-Task (CONSENSUS: NOT RECOMMENDED)

#### Traditional Ensembles (3-10 models)
- **Reports**: 4/4 evaluated
- **Consensus**: **❌ NOT RECOMMENDED**
- **Reason**: High cost (3-10x), modest gains (+1-3%)
- **Better alternatives**: Data augmentation, hyperparameters

#### Multi-Task Learning (Classification + NER)
- **Reports**: Ensemble report primary analysis
- **Consensus**: **⚠️ CONDITIONAL** (only if Phase 1-2 insufficient)
- **F1 Gain**: +1-3% (NER), +0.5-1% (Classification)
- **Risk**: HIGH (negative transfer, complex implementation)
- **Priority**: **LOW** (Phase 3 only)

#### Ensemble with Distillation
- **Reports**: Ensemble, Modern ML
- **Consensus**: **⚠️ MAYBE** (if maximum F1 needed after Phase 3)
- **Cost**: 6x training time (57 hours)
- **F1 Gain**: +1.8-2.2%
- **Priority**: **VERY LOW**

---

<a name="implementation-priorities"></a>
## Implementation Priorities Matrix

### Priority Levels

**CRITICAL (Week 1)**: Must implement, blocks everything else

| Action | F1 Gain | Complexity | Cost | Risk | Reports |
|--------|---------|------------|------|------|---------|
| Fix Learning Rate (2e-5 → 5e-6) | +2-3% | Trivial | $0 | None | 4/4 |
| Add Weight Decay (0.0 → 0.01) | +2-3% | Trivial | $0 | None | 4/4 |
| Implement Early Stopping | +3-5% | Low | $0 | None | 4/4 |
| Switch to BioLinkBERT-base | +2-3% | Low | $0 | Low | 3/4 |

**HIGH (Weeks 2-3)**: Should implement, high value

| Action | F1 Gain | Complexity | Cost | Risk | Reports |
|--------|---------|------------|------|------|---------|
| UMLS-EDA Augmentation | +5-17% | Low | $0 | Low | 2/4 |
| GPT-4 Data Generation | +3-8% | Medium | $30-50 | Low | 2/4 |
| LoRA Fine-Tuning | +0-3% | Low | $0 | Low | 2/4 |
| TAPT on 21K Papers | +8-15% | Medium | $0 | Low | 2/4 |
| Mixed Precision Training | 0% (2x speed) | Trivial | $0 | None | 1/4 |

**MEDIUM (Weeks 3-6)**: Nice to have, moderate value

| Action | F1 Gain | Complexity | Cost | Risk | Reports |
|--------|---------|------------|------|------|---------|
| Self-Training Pseudo-Labels | +5-12% | Medium | $0 | Medium | 2/4 |
| Contrastive Learning | +5-10% | Med-High | $0 | Medium | 2/4 |
| LLRD (Layer-wise LR) | +1-2% | Low | $0 | Low | 2/4 |
| Label Smoothing | +1-2% | Low | $0 | Low | 2/4 |
| Cosine Scheduler | +0.5-1.5% | Trivial | $0 | None | 2/4 |

**LOW (Weeks 6+)**: Optional enhancements

| Action | F1 Gain | Complexity | Cost | Risk | Reports |
|--------|---------|------------|------|------|---------|
| Multi-Task Learning | +1-3% | High | $0 | High | 1/4 |
| Prototypical Networks | +4-8% | High | $0 | Medium | 1/4 |
| Advanced Optimizers (Lion) | 0-2% | Low | $0 | Medium | 1/4 |

**SKIP**: Not recommended

| Action | Reason | Reports |
|--------|--------|---------|
| Traditional Ensembles (3-10 models) | High cost (3-10x), modest gains (+1-3%) | 4/4 |
| Model Quantization | -1-2% F1 penalty | 1/4 |
| Snapshot Ensembles / FGE | Unproven for transformers | 1/4 |

---

<a name="expected-outcomes"></a>
## Expected Outcomes Timeline

### Conservative Projection (High Confidence)

| Phase | Timeline | NER F1 | Classification F1 | Cumulative NER Gain | Confidence |
|-------|----------|--------|-------------------|---------------------|------------|
| **Baseline** | - | 0.749 | 0.898 | - | 100% |
| **Phase 1** | Week 1 | 0.800-0.820 | 0.910-0.920 | +7-9% | 90% |
| **Phase 2** | Weeks 2-3 | 0.850-0.870 | 0.910-0.920 | +13-16% | 75% |
| **Phase 3** | Weeks 4-6 | 0.870-0.880 | 0.920-0.930 | +16-17% | 60% |

### Optimistic Projection (Medium Confidence)

| Phase | Timeline | NER F1 | Classification F1 | Cumulative NER Gain | Confidence |
|-------|----------|--------|-------------------|---------------------|------------|
| **Baseline** | - | 0.749 | 0.898 | - | 100% |
| **Phase 1** | Week 1 | 0.820-0.840 | 0.920-0.930 | +9-12% | 70% |
| **Phase 2** | Weeks 2-3 | 0.870-0.890 | 0.920-0.930 | +16-19% | 60% |
| **Phase 3** | Weeks 4-6 | 0.890-0.900 | 0.930-0.940 | +19-20% | 40% |

### Expected F1 by Technique (Additive Estimates)

**NER Model**:

| Technique | F1 Contribution | Cumulative F1 |
|-----------|----------------|---------------|
| Baseline | - | 0.749 |
| + Hyperparameter fixes | +0.03-0.05 | 0.779-0.799 |
| + BioLinkBERT base model | +0.02-0.03 | 0.799-0.829 |
| + LoRA fine-tuning | +0.01-0.02 | 0.809-0.849 |
| + UMLS-EDA (1,600 samples) | +0.03-0.05 | 0.839-0.899 |
| + GPT-4 generation | +0.01-0.02 | 0.849-0.919 |
| + TAPT | +0.02-0.04 | **0.869-0.959** |
| + Self-training (optional) | +0.01-0.02 | 0.879-0.979 |

**Note**: Gains are not perfectly additive; expect 70-85% of sum due to overlap

**Classification Model**:

| Technique | F1 Contribution | Cumulative F1 |
|-----------|----------------|---------------|
| Baseline | - | 0.898 |
| + Hyperparameter fixes | +0.01-0.02 | 0.908-0.918 |
| + BioLinkBERT base model | +0.01-0.02 | 0.918-0.938 |
| **Final** | - | **0.918-0.938** |

---

<a name="cost-analysis"></a>
## Cost Analysis

### Financial Costs

| Item | Cost | When | Optional |
|------|------|------|----------|
| **UMLS License** | $0 (free registration) | Week 2 | No |
| **GPT-4 API** | $30-50 | Week 2 | Yes (can use GPT-3.5 for $5) |
| **Google Colab Pro** | $10/month | If exceeding free tier | Yes |
| **Total Financial** | **$40-60** | - | - |

### Time Investment

| Phase | Task | Time | Who | Parallelizable |
|-------|------|------|-----|----------------|
| **Phase 1** | Hyperparameter tuning | 2 days | Engineer | No |
| | Model testing (BioLinkBERT) | 1 day | Engineer | No |
| | LoRA implementation | 1 day | Engineer | Yes |
| | Full training + validation | 1 day | System | No |
| **Phase 2** | UMLS-EDA setup | 1 day | Engineer | No |
| | UMLS-EDA generation | 0.5 day | System | Yes |
| | GPT-4 prompt engineering | 0.5 day | Engineer | Yes |
| | GPT-4 generation | 0.5 day | System | Yes |
| | TAPT training | 1 day | System | No |
| | Quality validation | 2 days | Engineer | No |
| | Full training + validation | 1 day | System | No |
| **Phase 3** | Self-training impl | 2 days | Engineer | No |
| | Self-training iterations | 3 days | System | No |
| | Final validation | 1 day | Engineer | No |
| **Total** | - | **17-22 days** | - | - |

**Breakdown**:
- **Engineer time**: 10-12 days (active work)
- **System time**: 7-10 days (training, mostly unattended)
- **Wall-clock time**: 4-6 weeks (with parallelization)

### Resource Requirements

**Compute**:
- GPU: Google Colab T4 (free tier) or T4/V100 (Colab Pro)
- Memory: 15GB GPU memory (BioLinkBERT-base fits on T4)
- Storage: 20GB (models, datasets, UMLS)

**Data**:
- Training data: 1,635 classification + 1,500+ NER samples
- Unlabeled: 21,677 papers for TAPT
- UMLS: ~10GB

---

<a name="risk-assessment"></a>
## Risk Assessment

### High Risks (Requires Mitigation)

#### Risk 1: Data Augmentation Quality Issues
**Probability**: 30%
**Impact**: Medium (wasted augmented samples)

**Symptoms**:
- BIO tag inconsistencies
- Hallucinated database names (LLM generation)
- Semantically incorrect sentences

**Mitigation**:
1. Automated validation: BIO tag consistency checker
2. Manual review: 10-20% of augmented samples
3. Incremental approach: Validate 100 samples before generating 1,000
4. Filter aggressively: Keep only high-quality augmentations

**Fallback**: Use only UMLS-EDA (proven) if LLM generation quality is poor

---

#### Risk 2: TAPT Doesn't Improve Performance
**Probability**: 20%
**Impact**: Medium (6-8 hours wasted training time)

**Symptoms**:
- NER F1 unchanged or decreased after TAPT
- No improvement in domain-specific terminology recognition

**Mitigation**:
1. Test with small sample first (1,000 papers, 1 epoch)
2. Verify MLM loss decreases during TAPT
3. Check tokenizer compatibility

**Fallback**: Skip TAPT, rely on data augmentation only

---

#### Risk 3: Negative Transfer in Multi-Task Learning
**Probability**: 40% (if pursued)
**Impact**: High (1-2 weeks wasted, potential model degradation)

**Symptoms**:
- One task improves while other degrades
- Both tasks perform worse than single-task baselines
- Training instability

**Mitigation**:
1. Monitor both tasks independently during training
2. Implement gradient balancing (PCGrad)
3. Early stopping per task
4. Start with TEST_MODE to validate quickly

**Fallback**: Revert to single-task models if negative transfer detected

---

### Medium Risks (Monitor)

#### Risk 4: Hyperparameter Sensitivity
**Probability**: 30%
**Impact**: Medium (additional tuning time)

**Mitigation**: Grid search over 2-3 LR values, validate on test set

#### Risk 5: Colab Session Interruptions
**Probability**: 40%
**Impact**: Low (restart training)

**Mitigation**: Use checkpoints, Colab Pro for longer sessions

#### Risk 6: Model Size Too Large for T4
**Probability**: 10%
**Impact**: Low (use base model instead of large)

**Mitigation**: Stick with BioLinkBERT-base (110M), use gradient checkpointing if needed

---

### Low Risks (Accept)

- **LoRA underperforms**: Unlikely, well-proven technique
- **Modern base model worse than current**: Very unlikely, extensive benchmarks show improvements
- **UMLS-EDA low quality**: Unlikely, published results are strong

---

<a name="decision-framework"></a>
## Decision Framework

### When to Proceed to Next Phase

#### Phase 1 → Phase 2 Decision

**Proceed IF**:
- ✅ NER F1 ≥ 0.800 on validation set
- ✅ Training stable (no bouncing/divergence)
- ✅ Overfitting reduced (train/val gap < 0.20)
- ✅ Classification F1 ≥ 0.905

**Stop and Debug IF**:
- ❌ NER F1 < 0.780
- ❌ Training still unstable
- ❌ Classification F1 < 0.900

**Debug Actions**:
1. Check learning rate: Try 3e-6 or 1e-5
2. Increase weight decay: Try 0.05 or 0.1
3. Verify model loaded correctly
4. Review training logs for anomalies

---

#### Phase 2 → Phase 3 Decision

**Proceed IF**:
- ✅ NER F1 ≥ 0.850 on validation set
- ✅ Data augmentation successful (1,500+ quality samples)
- ✅ TAPT provided gain (or skipped intentionally)
- ✅ Goal F1 not yet reached

**Stop (Success) IF**:
- ✅ NER F1 ≥ 0.870 (target exceeded)
- ✅ Classification F1 ≥ 0.920
- ✅ Performance acceptable for production

**Skip Phase 3 IF**:
- ✅ Already met targets
- ❌ Limited time/resources remaining
- ❌ Risk appetite low

---

### Multi-Task Learning Decision Tree

```
Should you pursue Multi-Task Learning?
│
├─ Is NER F1 < 0.850 after Phase 2?
│  ├─ NO → Skip MTL, already successful
│  └─ YES → Continue
│      │
│      ├─ Do you have 2 weeks for implementation?
│      │  ├─ NO → Skip MTL, try self-training instead
│      │  └─ YES → Continue
│      │      │
│      │      ├─ Can you accept HIGH risk of negative transfer?
│      │      │  ├─ NO → Skip MTL, not worth risk
│      │      │  └─ YES → Proceed with MTL
│      │      │      │
│      │      │      ├─ Implement with:
│      │      │      │  - Task balancing (λ₁=0.3, λ₂=0.7)
│      │      │      │  - Gradient balancing (PCGrad)
│      │      │      │  - Independent validation per task
│      │      │      │
│      │      │      └─ Stop IF negative transfer detected (>2% drop either task)
```

---

### Self-Training Decision Tree

```
Should you pursue Self-Training?
│
├─ Is NER F1 < 0.870 after Phase 2?
│  ├─ NO → Skip self-training, already successful
│  └─ YES → Continue
│      │
│      ├─ Do you have 21,677 unlabeled papers available?
│      │  ├─ NO → Cannot proceed
│      │  └─ YES → Continue
│      │      │
│      │      ├─ Is baseline model F1 ≥ 0.800?
│      │      │  ├─ NO → Fix baseline first
│      │      │  └─ YES → Proceed with self-training
│      │      │      │
│      │      │      ├─ Start with confidence threshold=0.95
│      │      │      ├─ Run 1 iteration (3 days)
│      │      │      ├─ Validate: Did F1 improve?
│      │      │      │  ├─ YES → Continue iterations
│      │      │      │  └─ NO → Increase threshold to 0.98 or stop
```

---

### Success Criteria by Phase

**Phase 1 Success**:
- ✅ NER F1 ≥ 0.800 (baseline: 0.749)
- ✅ Training stable and reproducible
- ✅ Overfitting reduced (train/val gap < 0.20)

**Phase 2 Success**:
- ✅ NER F1 ≥ 0.850 (baseline: 0.749)
- ✅ Dataset expanded to 1,500+ samples
- ✅ Classification F1 ≥ 0.915

**Phase 3 Success** (if pursued):
- ✅ NER F1 ≥ 0.870 (baseline: 0.749)
- ✅ Classification F1 ≥ 0.920
- ✅ Stable production-ready models

**Overall Success**:
- ✅ NER F1 improvement ≥ +10% (0.749 → 0.849+)
- ✅ Classification F1 improvement ≥ +2% (0.898 → 0.918+)
- ✅ Models ready for 2023+ data processing
- ✅ Training pipeline stable and documented

---

<a name="references"></a>
## Detailed Report Links

### Core Research Reports

1. **[Modern ML Alternatives Research Report](MODERN_ML_ALTERNATIVES_RESEARCH_REPORT.md)**
   - 28,000 tokens, comprehensive survey
   - Topics: BioLinkBERT, LoRA/QLoRA, modern optimizers, mixed precision
   - Key finding: Hyperparameters > new models/techniques

2. **[Data Augmentation NER Research Report](DATA_AUGMENTATION_NER_RESEARCH_REPORT.md)**
   - 30,000 tokens, focused on NER dataset expansion
   - Topics: UMLS-EDA, LLM generation, entity-preserving techniques
   - Key finding: UMLS-EDA +5-17% F1 (proven)

3. **[Few-Shot Meta-Learning Research Report](FEW_SHOT_META_LEARNING_RESEARCH_REPORT.md)**
   - 25,000 tokens, small dataset optimization
   - Topics: TAPT, self-training, contrastive learning, prototypical networks
   - Key finding: TAPT + regularization = +8-15% F1

4. **[Ensemble & Multi-Task Research Report](ENSEMBLE_MULTITASK_RESEARCH_REPORT.md)**
   - 15,000 tokens, advanced techniques
   - Topics: Ensembles, multi-task learning, knowledge distillation
   - Key finding: NOT RECOMMENDED (high cost, modest gains)

---

## Implementation Checklist

### Phase 1 (Week 1)
- [ ] Update training config: LR=5e-6, weight_decay=0.01
- [ ] Implement early stopping callback (patience=3)
- [ ] Add cosine LR scheduler
- [ ] Switch to BioLinkBERT-base
- [ ] Implement LoRA fine-tuning
- [ ] Train classification model with new config
- [ ] Train NER model with new config
- [ ] Validate on test set
- [ ] Compare to V2 baseline
- [ ] Document results and optimal hyperparameters

### Phase 2 (Weeks 2-3)
- [ ] Setup UMLS license and QuickUMLS
- [ ] Install UMLS-EDA library
- [ ] Generate UMLS-EDA augmented data (554 → 1,600)
- [ ] Validate augmented data quality (10% manual review)
- [ ] Setup OpenAI API for GPT-4
- [ ] Develop prompts for entity generation
- [ ] Generate GPT-4 synthetic data (200-300 samples)
- [ ] Validate GPT-4 data quality
- [ ] Combine datasets (1,500+ total)
- [ ] Prepare TAPT corpus (21,677 papers)
- [ ] Run TAPT training (3 epochs, 6-8 hours)
- [ ] Fine-tune NER on TAPT + augmented data
- [ ] Validate on test set
- [ ] Analyze performance gains

### Phase 3 (Weeks 4-6, Optional)
- [ ] Decide: Self-training vs Contrastive vs MTL
- [ ] If self-training: Implement pseudo-labeling pipeline
- [ ] If self-training: Run 3 iterations
- [ ] If contrastive: Implement token-level contrastive loss
- [ ] If MTL: Implement multi-task architecture
- [ ] If MTL: Monitor for negative transfer
- [ ] Final validation on test set
- [ ] A/B comparison with V2 baseline
- [ ] Document final results
- [ ] Prepare for production deployment

---

## Final Recommendations Summary

### DO THIS (High Priority)

1. **Fix hyperparameters immediately** - Single biggest impact (+7-9% F1)
2. **Switch to BioLinkBERT-base** - Proven modern biomedical model (+2-3% F1)
3. **Implement data augmentation** - UMLS-EDA + GPT-4 (+8-15% F1)
4. **Use LoRA fine-tuning** - Reduces overfitting, saves memory
5. **Run TAPT on unlabeled papers** - Leverage your 21,677 papers (+8-15% F1)

### MAYBE DO THIS (Medium Priority, Phase 3)

6. **Self-training with pseudo-labels** - If F1 < 0.850 after Phase 2
7. **Contrastive learning** - If need additional gains
8. **Multi-task learning** - ONLY if F1 < 0.850 AND willing to accept risk

### DON'T DO THIS (Low Value, High Cost)

9. **Traditional ensembles** (3-10 models) - 3-10x cost for +1-3% gain
10. **Snapshot ensembles / FGE** - Unproven for transformers
11. **Advanced optimizers** (Lion, Sophia) - No advantage over AdamW with proper tuning
12. **Model quantization** - -1-2% F1 penalty

---

## Expected Total Improvement (Conservative)

**Starting Point**:
- Classification F1: 0.898
- NER F1: 0.749

**After Phase 1** (Week 1):
- Classification F1: 0.910-0.920 (+1-2%)
- NER F1: 0.800-0.820 (+7-9%)

**After Phase 2** (Weeks 2-3):
- Classification F1: 0.910-0.920 (stable)
- NER F1: 0.850-0.870 (+13-16% total)

**After Phase 3** (Weeks 4-6, if pursued):
- Classification F1: 0.920-0.930 (+2-3% total)
- NER F1: 0.870-0.880 (+16-17% total)

**Total Project Impact**:
- **NER: +10-18% F1 improvement** (0.749 → 0.859-0.867)
- **Classification: +2-5% F1 improvement** (0.898 → 0.918-0.948)
- **Cost**: $40-60
- **Time**: 4-6 weeks
- **Confidence**: 75% (Phase 1-2), 60% (Phase 3)

---

**Report Completed**: 2025-10-29
**Total Research**: 4 reports, 100+ papers, 12+ hours research time
**Recommendation Confidence**: HIGH (extensive literature support, consensus across reports)
**Ready for**: Immediate implementation (Phase 1)
